Total Payments
$5,717
2024 Payments
$1,023
Companies
21
Transactions
280
Medicare Patients
442
Medicare Billing
$180,945
Payment Breakdown by Category
Food & Beverage$5,664 (99.1%)
Education$53.73 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,664 | 275 | 99.1% |
| Education | $53.73 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $882.79 | 32 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $773.42 | 42 | $0 (2024) |
| ABBVIE INC. | $730.03 | 38 | $0 (2024) |
| Allergan, Inc. | $703.50 | 37 | $0 (2020) |
| Lundbeck LLC | $506.48 | 24 | $0 (2024) |
| ITI, Inc. | $345.26 | 21 | $0 (2023) |
| Shire North American Group Inc | $252.21 | 13 | $0 (2019) |
| Bausch Health US, LLC | $244.11 | 12 | $0 (2019) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $217.10 | 10 | $0 (2024) |
| Axsome Therapeutics, Inc. | $211.73 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,023 | 46 | Takeda Pharmaceuticals U.S.A., Inc. ($301.79) |
| 2023 | $752.42 | 42 | ABBVIE INC. ($303.49) |
| 2022 | $484.04 | 27 | ABBVIE INC. ($197.78) |
| 2020 | $248.64 | 11 | Lundbeck LLC ($90.04) |
| 2019 | $1,043 | 51 | Allergan Inc. ($226.22) |
| 2018 | $1,187 | 54 | Otsuka America Pharmaceutical, Inc. ($348.70) |
| 2017 | $980.27 | 49 | Otsuka America Pharmaceutical, Inc. ($258.27) |
All Payment Transactions
280 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.21 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.21 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: PSYCHIATRY | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.54 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $34.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.14 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 86 | 349 | $71,700 | $39,970 |
| 2022 | 2 | 91 | 381 | $77,850 | $44,452 |
| 2021 | 3 | 138 | 410 | $86,800 | $49,623 |
| 2020 | 3 | 127 | 425 | $85,000 | $46,899 |
Total Patients
442
Total Services
1,565
Medicare Billing
$180,945
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 320 | $64,000 | $35,497 | 55.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 29 | $7,700 | $4,473 | 58.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 356 | $71,200 | $40,167 | 56.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 25 | $6,650 | $4,285 | 64.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 284 | $56,800 | $32,835 | 57.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 63 | $17,400 | $9,176 | 52.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 27 | 63 | $12,600 | $7,612 | 60.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 45 | 165 | $33,000 | $21,952 | 66.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 60 | 221 | $44,200 | $20,901 | 47.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 39 | $7,800 | $4,046 | 51.9% |
About Dr. Charles Kandalaft, MD
Dr. Charles Kandalaft, MD is a Psychiatry healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467499798.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Kandalaft, MD has received a total of $5,717 in payments from pharmaceutical and medical device companies, with $1,023 received in 2024. These payments were reported across 280 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($5,664).
As a Medicare-enrolled provider, Kandalaft has provided services to 442 Medicare beneficiaries, totaling 1,565 services with total Medicare billing of $180,945. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Valhalla, NY
- Active Since 06/02/2006
- Last Updated 01/02/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1467499798
Products in Payments
- VRAYLAR (Drug) $1,364
- REXULTI (Drug) $955.64
- CAPLYTA (Drug) $562.36
- TRINTELLIX (Drug) $522.21
- Trintellix (Drug) $366.08
- ABILIFY MAINTENA (Drug) $340.61
- Auvelity (Drug) $211.73
- NUEDEXTA (Drug) $184.84
- VYVANSE (Drug) $182.00
- LATUDA (Drug) $176.52
- APLENZIN (Drug) $158.52
- SPRAVATO (Drug) $129.66
- MYDAYIS (Drug) $94.47
- BRINTELLIX (Drug) $93.02
- VIIBRYD (Drug) $69.14
- SUNOSI (Drug) $52.57
- MIGRANAL (Drug) $46.53
- AUSTEDO (Drug) $39.74
- WELLBUTRIN (Drug) $39.06
- BELSOMRA (Drug) $37.36
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Valhalla
Harvey Berman, Md, MD
Psychiatry — Payments: $13,458
Psychiatry $13,458
Dr. Alan Kaye, M.d, M.D
Psychiatry — Payments: $4,921
Psychiatry $4,921
Anna Gomberg, Md, MD
Psychiatry — Payments: $3,880
Psychiatry $3,880
Alice Jiang, Do, DO
Psychiatry — Payments: $3,292
Psychiatry $3,292
Jaime Grodzicki, Md, MD
Psychiatry — Payments: $2,777
Psychiatry $2,777
Dr. Gony Weiss, M.d, M.D
Psychiatry — Payments: $2,292
Psychiatry $2,292